An official website of the United States government
NIH Websites Are Changing Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Status: active
This is a Phase I/II study designed to evaluate if experimental T cell engaging antibody
targeting CD20 AZD5492 is safe, tolerable and efficacious in participants with Relapsed
or Refractory B-Cell Malignancies.